T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
2301
Franklin Street Properties
FSP
$46.4M
| $285K | ﹤0.01% |
45,809
+14,367
| +46% | +$106K |
|
2302
LeMaitre Vascular
LMAT
$1.87B
| $284K | ﹤0.01% |
12,013
-3,671
| -23% | -$100K |
|
2303
Tootsie Roll Industries
TR
$3.02B
| $284K | ﹤0.01% |
10,784
+27
| +0.3% | +$689 |
|
|
OSG
2304
Octave Specialty Group
OSG
$212M
| $283K | ﹤0.01% |
+16,412
| New | +$301K |
|
|
CASI
2305
DELISTED
CASI Pharmaceuticals
CASI
| $283K | ﹤0.01% |
7,047
+2,046
| +41% | +$77.5K |
|
2306
Unitil
UTL
$992M
| $283K | ﹤0.01% |
5,597
+26
| +0.5% | +$1.29K |
|
|
MOBL
2307
DELISTED
MobileIron, Inc.
MOBL
| $283K | ﹤0.01% |
61,587
+157
| +0.3% | +$735 |
|
|
RESI
2308
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $281K | ﹤0.01% |
32,200
+72
| +0.2% | +$674 |
|
|
UMH
2309
UMH Properties
UMH
$1.42B
| $280K | ﹤0.01% |
23,641
+70
| +0.3% | +$948 |
|
2310
1-800-Flowers.com
FLWS
$261M
| $279K | ﹤0.01% |
22,830
+8,448
| +59% | +$101K |
|
|
RVNC
2311
DELISTED
Revance Therapeutics, Inc.
RVNC
| $279K | ﹤0.01% |
+13,845
| New | +$305K |
|
2312
Chefs' Warehouse
CHEF
$4.57B
| $278K | ﹤0.01% |
8,694
+38
| +0.4% | +$1.32K |
|
|
TELL
2313
DELISTED
Tellurian Inc.
TELL
| $278K | ﹤0.01% |
39,971
-90,715
| -69% | -$701K |
|
|
DERM
2314
DELISTED
Dermira, Inc.
DERM
| $278K | ﹤0.01% |
38,730
-13,041
| -25% | -$143K |
|
2315
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
| $277K | ﹤0.01% |
+5,950
| New | +$294K |
|
|
CNBKA
2316
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $277K | ﹤0.01% |
4,089
+5
| +0.1% | +$385 |
|
2317
Western New England Bancorp
WNEB
$282M
| $276K | ﹤0.01% |
27,466
+53
| +0.2% | +$526 |
|
|
FRED
2318
DELISTED
Fred's Inc
FRED
| $276K | ﹤0.01% |
146,000
-137,025
| -48% | -$356K |
|
|
OMN
2319
DELISTED
OMNOVA Solutions Inc.
OMN
| $275K | ﹤0.01% |
37,492
+75
| +0.2% | +$604 |
|
2320
Artesian Resources
ARTNA
$369M
| $273K | ﹤0.01% |
7,817
+315
| +4% | +$11.4K |
|
2321
Medpace
MEDP
$16.2B
| $273K | ﹤0.01% |
5,164
+318
| +7% | +$17.5K |
|
2322
Universal Electronics
UEIC
$66.6M
| $273K | ﹤0.01% |
10,787
+2,704
| +33% | +$87.5K |
|
2323
Citizens
CIA
$198M
| $272K | ﹤0.01% |
36,105
+97
| +0.3% | +$762 |
|
2324
Stride
LRN
$3.48B
| $272K | ﹤0.01% |
+10,974
| New | +$234K |
|
2325
Griffon
GFF
$4.8B
| $271K | ﹤0.01% |
25,974
+7,165
| +38% | +$91K |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.